KORU Medical Systems, Inc. (KRMD)
(Delayed Data from NSDQ)
$3.26 USD
-0.02 (-0.61%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $3.27 +0.01 (0.31%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
KRMD 3.26 -0.02(-0.61%)
Will KRMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KRMD
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
KRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
Integer (ITGR) Soars 3.8%: Is Further Upside Left in the Stock?
Other News for KRMD
KORU Medical raises FY25 revenue view to $39.5M-$40.5M from $38.5M-$39.5M
KORU Medical reports Q2 adjusted EPS 1c, consensus (2c)
KORU Medical Systems Inc Reports Q2 2025 Earnings: EPS at $0. ...
Earnings Scheduled For August 6, 2025
KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit ...